Sichenzia Ross Ference Kesner LLP Represents Cannabinoid Based Therapeutics Company in $12.3 Million Private Placement Led by Tuatara Capital Fund I, Ltd.
Press Release – New York, NY – March 2, 2017 – Securities and corporate law firm Sichenzia Ross Ference Kesner LLP is pleased to announce that the firm has represented a cannabinoid based life sciences corporation whose technology is designed to synthetically produce medically beneficial cannabinoids without utilizing the actual cannabis plant for the customized treatment of disease. Last year, Tuatara and its affiliates invested $7.0 million in a Series A Financing for the company. The Sichenzia Ross Ference Kesner LLP team was led by partners Darrin M. Ocasio and Arthur Marcus and associate Ashley Jaber. Sichenzia Ross Ference Kesner LLP is a leader in the representation of cannabis related companies.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP代表A.G.P / Alliance Global Partners进行350万美元的Safe-T Group Ltd公开发售。 - November 6, 2019
- Sichenzia Ross Ference LLP代表Document Security Systems，Inc.进行180万美元的私募 - November 5, 2019
- Sichenzia Ross Ference LLP代表Aegis Capital Corp.完成对Cocrystal Pharma，Inc. 300万美元普通股的公开发行。 - November 4, 2019